Binocular Vision in Monocular Pseudophakia (BVMP)

June 12, 2019 updated by: University of Oxford

A Prospective Randomised Controlled Trial to Assess Improved Binocular Visual Function in Young Patients Undergoing Monocular Cataract Surgery With a Bifocal Intraocular Lens.

Following cataract surgery, an intraocular lens (IOL) is implanted in the eye. The majority of people develop an operable cataract when they are over the age of 50. Occasionally people under 50 years develop a cataract requiring an operation. The visual demands in this age group are very different due to both physiological and lifestyle factors. Traditionally IOLs are focussed for distance vision and additional spectacles are worn for near vision. Under the age of 45 years we have the ability to naturally change the focus of our eyes and do not require additional reading glasses. This is known as accommodation. By removing the cataractous lens and replacing it with an IOL with a fixed single focus, both eyes work together for distance vision but only the unoperated eye is able to change focus for different working distances. This study aims to establish whether a multifocal IOL implanted in one eye is able to complement the accommodation in the other eye so the 2 eyes work more effectively together. This may enhance depth perception and improve the quality of vision. Depth perception is important for more comfortable vision on the computer screen, when reading and for jobs that require good depth perception.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aylesbury, United Kingdom
        • Stoke Mandeville Hospital
    • Oxfordshire
      • Oxford, Oxfordshire, United Kingdom, OX3 9DU
        • Oxford University Hospitals NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or female, aged 18 - 45.
  • Cataract operation required in one eye only, either due to the presence of cataract affecting visual function, or in combination with surgery which is likely to cause visually significant cataract.
  • Expected visual improvement in operable eye of at least 6/12.
  • Fellow eye with a VA of at least 6/9.
  • Astigmatism of 1.0D or less.
  • Target of emmetropia in the operated eye.
  • Intact posterior capsule with planned implantation into the capsular bag.
  • IOL power required 10 - 30D.

Exclusion Criteria:

  • Pre-existing amblyopia or squint.
  • Significant diabetic retinopathy.
  • Macular off retinal detachment with metamorphopsia or poor visual prognosis.
  • Other macula or ophthalmic pathology affecting macula function resulting in poor visual prognosis.
  • Pregnancy, lactating or planned pregnancy during the study period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Multifocal IOL
Phacoemulsification and IOL inserted following cataract surgery
Other Names:
  • Phacoemulsification and IOL insertion
Active Comparator: Standard IOL
Phacoemulsification and IOL inserted following cataract surgery
Other Names:
  • Phacoemulsification and IOL insertion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Extent of binocular vision at near working distance following IOL implantation.
Time Frame: 3-6 months
3-6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in visual acuity and subjective visual comfort at distance, intermediate and near working distances following IOL implantation.
Time Frame: 3-6 months
Visual acuity at different distances will be presented in combination as they are linked.
3-6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

October 1, 2018

Study Completion (Actual)

October 1, 2018

Study Registration Dates

First Submitted

May 1, 2013

First Submitted That Met QC Criteria

June 4, 2013

First Posted (Estimate)

June 7, 2013

Study Record Updates

Last Update Posted (Actual)

June 13, 2019

Last Update Submitted That Met QC Criteria

June 12, 2019

Last Verified

October 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BVMP2013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on Cataract surgery

Subscribe